Lyell Immunopharma's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Lyell Immunopharma last closed at $8.79 (+2.69%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -0.8×. Its overall grade ranks 663 of 738 stocks in Healthcare.
About this company
Lyell Immunopharma last closed at $8.79 (+2.69%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 663/738
Valuation grade C
Related stocks
- Gilead SciencesCompetitor
세포·유전자치료 및 면역항암 파이프라인에서 경쟁 구도
- NovartisCompetitor
세포치료/면역항암 치료제 개발 경쟁사
- Bristol Myers SquibbCompetitor
CAR-T·면역항암 분야의 대형 경쟁사
About Lyell Immunopharma
- What technical signals does Lyell Immunopharma (LYEL) have?
- Lyell Immunopharma current technical signals: no active technical signal.
- Is Lyell Immunopharma a cup-and-handle pattern?
- No. Lyell Immunopharma has no valid Cup signal right now.
- What published figures are available for Lyell Immunopharma?
- Market cap: $186.73M. Trailing 12 months PER: -0.8×. Latest quarter PBR: 0.88×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Lyell Immunopharma, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.